Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus
- PMID: 16621023
- DOI: 10.1016/j.vetimm.2006.02.007
Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus
Abstract
In horses, equine influenza virus (EIV) is a leading cause of respiratory disease. Conventional inactivated vaccines induce a short-lived immune response. By comparison, natural infection confers a long-term immunity to re-infection. An aim of new equine influenza vaccines is to more closely mimic natural infection in order to achieve a better quality of immunity. A new live recombinant vaccine derived from the canarypox virus vector and expressing haemagglutinin genes of EIV (subtype H3N8) has been developed. Stimulation of the immune system was studied after immunisation with this canarypox-based vaccine and challenge infection by exposure to a nebulised aerosol of EIV. The humoral immune response was evaluated by measuring serum antibody levels using the single radial haemolysis (SRH) assay. The cellular immune response was assessed by the measurement of interferon gamma (IFN-gamma) synthesis in peripheral blood mononuclear cells (PBMC). Clinical signs of the disease (temperature, coughing, nasal discharge, dyspnoea, depression and anorexia) and virus excretion were monitored after challenge infection. Clinical signs and virus shedding were significantly reduced in vaccinates compared with unvaccinated controls. EIV-specific immunity was stimulated by vaccination with a recombinant vaccine as serological responses were detected after immunisation. This study also provided the first evidence for increased IFN-gamma protein synthesis in vaccinated ponies following challenge infection with EIV compared with control ponies.
Similar articles
-
Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.Vet Res. 2008 May-Jun;39(3):21. doi: 10.1051/vetres:2007062. Epub 2008 Feb 7. Vet Res. 2008. PMID: 18252187 Clinical Trial.
-
Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.Am J Vet Res. 2007 Feb;68(2):213-9. doi: 10.2460/ajvr.68.2.213. Am J Vet Res. 2007. PMID: 17269889 Clinical Trial.
-
Humoral and cell-mediated immune responses of old horses following recombinant canarypox virus vaccination and subsequent challenge infection.Vet Immunol Immunopathol. 2011 Feb 15;139(2-4):128-40. doi: 10.1016/j.vetimm.2010.09.006. Epub 2010 Oct 7. Vet Immunol Immunopathol. 2011. PMID: 21035197
-
Current perspectives on control of equine influenza.Vet Res. 2004 Jul-Aug;35(4):411-23. doi: 10.1051/vetres:2004023. Vet Res. 2004. PMID: 15236674 Review.
-
Vaccination against equine influenza: quid novi?Vaccine. 2006 May 8;24(19):4047-61. doi: 10.1016/j.vaccine.2006.02.030. Epub 2006 Feb 28. Vaccine. 2006. PMID: 16545507 Review.
Cited by
-
Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory TR1 cell activation and a delay of the Th2 cell response in equine neonates and foals.Vet Res. 2010 Jul-Aug;41(4):47. doi: 10.1051/vetres/2010019. Epub 2010 Apr 9. Vet Res. 2010. PMID: 20374696 Free PMC article.
-
Impact of Mixed Equine Influenza Vaccination on Correlate of Protection in Horses.Vaccines (Basel). 2018 Oct 4;6(4):71. doi: 10.3390/vaccines6040071. Vaccines (Basel). 2018. PMID: 30287762 Free PMC article.
-
Equine Influenza Virus and Vaccines.Viruses. 2021 Aug 20;13(8):1657. doi: 10.3390/v13081657. Viruses. 2021. PMID: 34452521 Free PMC article. Review.
-
Assessment of Humoral and Long-Term Cell-Mediated Immune Responses to Recombinant Canarypox-Vectored Equine Influenza Virus Vaccination in Horses Using Conventional and Accelerated Regimens Respectively.Vaccines (Basel). 2022 May 26;10(6):855. doi: 10.3390/vaccines10060855. Vaccines (Basel). 2022. PMID: 35746463 Free PMC article.
-
Evaluation of Current Equine Influenza Vaccination Protocols Prior to Shipment, Guided by OIE Standards.Vaccines (Basel). 2020 Feb 29;8(1):107. doi: 10.3390/vaccines8010107. Vaccines (Basel). 2020. PMID: 32121419 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical